Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.37 (
CNPase
)
539
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of
glia maturation factor
(
GMF
) on cell proliferation and differentiation were investigated with 3 astroglioma cells (GE-12, C6, and GA-1), Schwannoma-like cells (354A), and mixed glioma cells (LRM-55). In the exponentially growing phase the growth rates of all glioma cells were enhanced by
GMF
regardless of the presence or absence of serum, but the factor failed to make the saturation density surpass the control level observed in the medium without
GMF
even in the chemically defined medium (N2 medium).
GMF
markedly lowered the saturation density of Schwannoma-like cells in N2 medium. Although
GMF
increased the intracellular content of S-100 protein 10-fold and
2',3'-cyclic nucleotide phosphohydrolase
activity 1.5-fold in Schwannoma-like cells,
GMF
conversely decreased the S-100 contents and glycerol phosphate dehydrogenase activity in astroglioma cells. All the astroglioma cells secreted into the culture medium large quantities of a growth-promoting factor(s) which had similar chemical properties to those of
GMF
and stimulated the proliferation of normal glioblasts; but Schwannoma-like cells did not, although they produced a small amount of such a factor(s). These findings imply that astroglioma cells are deprived of the differentiation-promoting response to
GMF
while Schwannoma-like cells still preserve the response in addition to the proliferative response to
GMF
.
...
PMID:The absence of differentiation-promoting response of astroglioma cells to glia maturation factor. 632 49